About FLX Bio

FLX Bio, Inc. is a biotechnology company focused on the discovery and development of novel therapies that will improve and prolong the lives of people with cancer. The company is targeting key cancer pathways with its clinical-stage program, FLX925, and building a pipeline of immuno-oncology oral medicines designed to activate a patient’s own immune system to eradicate cancer.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Phone number
+116504899000
location icon
Headquarter
South San Francisco, California
description icon
Founded
Apri

FLX Bio Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about FLX Bio

Who are the decision makers in FLX Bio?

The decision makers in FLX Bio are Karen L, Paul Kassner, etc. Click to Find FLX Bio decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more